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Abstract: New series of organotin(IV) complexes of aniline derivatives, R2SnL2 
and R3SnL [where R = Me, n-Bu, Ph, n-Oct] have been synthesized by the 
reaction of HL1 and HL2 with respective organotin halides or oxides. Experi-
mental details for the preparation and characterization (including elemental 
analysis, IR and multinuclear NMR (1H-, 13C- and 119Sn-) spectra in CDCl3 and 
EI mass spectra of both series are provided. The binding sites of the ligands 
were identified by means of FTIR spectroscopic measurements. It was found 
that in all cases the organotin(IV) moiety reacts with the oxygen of COO– group 
to form new complexes. In the diorganotin complexes, the COO– group is co-
ordinated to the organotin(IV) centres in a bidentate manner in the solid state. 
The 119Sn NMR data and the nJ(13C–119/117Sn) coupling constant support the 
tetrahedral coordination geometry of the organotin complexes in non-coordi-
nating solvents. Biological activities (antibacterial, antifungal, cytotoxicity, an-
tileishmanial and insecticidal) of these compounds are also reported. 
Keywords: organotin(IV) carboxylates; IR; multinuclear NMR (1H, 13C and 119Sn); 
mass spectrometry; biological activity. 
INTRODUCTION 
The chemistry of organotin(IV) complexes has developed considerably du-
ring the last 30 years, highlighting the syntheses of a number of complexes with 
interesting properties.1–3 Organotin carboxylates are widely used owing to their 
potential biocidal activity4 and cytotoxicity,5 as well as to their industrial and 
agricultural applications.6–10 In general, the biocidal activity of organotin com-
plexes is greatly influenced by the molecular structures and coordination number 
of the tin atom.11 
                                                                                                                    
* Corresponding author. E-mail: drsa54@yahoo.com 
2009 Copyright (CC) SCS142  SHAHID, SHAHZADI and ALI 
The environmental and biological chemistry of organotin(IV) carboxylates 
have been the subject of interest for some time, due to their increasingly wide-
spread use in industry and agriculture.12–16 Our current interest focuses on the 
synthesis, characterization and biological studies of different aniline derivatives 
of carboxylic acids. 
EXPERIMENTAL 
Physical measurements 
Melting points were determined in capillary tubes using a MP-D Mitamura Riken Kogyo 
(Japan) electrothermal melting point apparatus and are uncorrected. Infrared absorption spec-
tra (4000–400 cm-1) were recorded as KBr pellets on a Bio-rad FTIR spectrophotometer. 
1H-, 13C- and 119Sn-NMR spectra were recorded on a Bruker AM 250 spectrometer (Ger-
many), using CDCl3 as an internal reference (δ 1H(CDCl3) = 7.25 and δ 13C(CDCl3) = 77.0). 
Coupling constants (in H2) are given in brackets. 119Sn-NMR spectra were obtained with 
Me4Sn as the external reference (δ (Sn) = 37.290665). The numbering schemes for the orga-
notin(IV) derivatives of HL1 and HL2 are given in Schemes 1 and 2, respectively.  
Mass spectral data were measured on a MAT 8500 Finnigan 70 eV mass spectrometer 
(Germany). 
Materials and chemicals 
Organotin compounds are moisture and air sensitive; hence, the reactions were perfor-
med under an inert atmosphere. All the glass apparatus with standard quick fit joints used 
throughout the work were cleaned and dried at 120 °C. Di- and tri-organotin(IV) salts were 
purchased from Aldrich. All other reagents were of the purest grade available. Solvents were 
purified as in previously published methods.17 The anhydrides and 2,4-dinitroaniline were 
commercial products and used without further purification. 
General procedure for the synthesis of the ligands (HL1, HL2) 
A solution of anhydride (1 mmol) in acetic acid (300 ml) was added to a solution of 2,4- 
-dinitroaniline (1 mmol) in acetic acid (150 ml) and the mixture was stirred at room tem-
perature overnight. The coloured precipitates formed were filtered off, washed with cold dis-
tilled H2O (200 ml) and air-dried. The general chemical reaction is given by Eqs. (1) and (2). 
For HL1: 
RN H 2  + O
O
O
i) Glacial acetic acid
ii) Overnight stirring
RN HC
O
CH CH C
O
OH
 
(
1) 
For HL2: 
RN H 2  +
C
O
C
O
O
i) Glacial acetic acid
ii) Overnight stirring
RN HC C
O O
OH
 
(
2) 
2009 Copyright (CC) SCS  ORGANOTIN(IV) CARBOXYLATES  143 
where 
R =
NO2
O2N
General procedure for the synthesis of the di/tri-organotin(IV) complexes 
The ligand (5 mmol) was suspended in dry toluene (100 ml) and treated with triethyl-
amine (0.59 ml, 5 mmol). The mixture was refluxed for 2–4 h. To a reaction mixture, diorga-
notin dichloride or triorganotin chloride (2.5 mmol/5 mmol) was added as a solid to the re-
action flask under constant stirring and then refluxed for 8–10 h. The reaction mixture con-
taining Et3NHCl was filtered off such that the filtrate contained the organotin(IV) derivative. 
The solvent was removed under reduced pressure using a rotary evaporation (Eqs. (3) and (4)). 
However, for Oct2Sn(L1/L2)2, 5 mmol of the ligand HL1/HL2 was suspended in dry toluene 
(100 ml), solid Oct2SnO (2.5 mmol) was added under constant stirring and refluxed for 8–10 h. 
The formed water was removed via a Dean-Stark trap. After cooling to room temperature, the 
solvent was removed under reduced pressure using a rotary evaporator (Eq. (5)). 
The general chemical reactions for the synthesis of the di/triorganotin compounds are 
given by Eqs. (3)–(5). 
R2SnCl2 + 2HL
2Et3N
R2SnL2 + 2Et3NHCl  (3) 
R3SnCl + HL
Et3N
R3SnL + Et3NHCl  (4) 
R2SnO + 2HL → R2SnL2 + H2O  (5) 
 
Scheme 1. NMR numbering scheme for the organotin(IV) derivatives of 
4-[(2,4-dinitrophenyl)amino]-4-oxo-2-butenoic acid (HL1). 
Biological activity 
Antibacterial activities. The antibacterial activities were determined using the agar well 
diffusion method.18 Wells (diameter, 25 mm) were made in the media with a sterile borer and 
an eight-hour-old bacterial inoculum containing ca. 104–106 colony forming units (CFU)/mL 
was spread on the surface of the nutrient agar using a sterile cotton swab. The recommended 
concentration of the test sample (2 mg/mL in DMSO) was introduced into the respective 
wells. Other wells containing DMSO and the reference antibacterial drug served as negative 
and positive controls, respectively. The plates were incubated immediately at 37 °C for 20 h. 
The activity was determined by measuring the diameter (in mm) of the inhibition zone 
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showing complete inhibition. Growth inhibition was calculated with reference to the positive 
control. 
LD50 data of the compounds were determined by the brine-shrimp assay method.18 
Insecticidal activity. The insects were exposed to the test compounds by the contact 
method18 using filter paper. Different concentrations of every compound (1 ml) were applied 
by micropipette to 90 mm diameter filter papers, which were then placed in petri dishes. 
Subsequently, four adult insects of the same size and age of each batch were transferred to the 
petri dishes. A control batch was treated with solvent for the determination of the environ-
mental effects. Another batch was supplemented with reference insecticides, i.e., Coopex and 
Decis (synthetic pyrethroids). All batches were kept without food throughout the 24 h expo-
sure period, after which the mortality counts were determined. 
Antileishmanial activity. Leishmania promastigotes were grown in bulk early in a liquid 
medium RPMI-1640 supplemented with 10 % foetal calf serum. At the log phase, the 
parasites were centrifuged at 2000 rpm for 10 min and the old medium was discarded. The 
parasites were diluted with fresh culture medium to a final density of 106 cells ml-1. 100 µl of 
the culture was added in all the wells, except the first column, which received 180 µl. The last 
two rows of the microtiter plate were control containing varying concentrations of standard 
antileishmanial compounds, e.g., amphotericin B or pentmidine. 
The samples were prepared by dissolving 1.0 mg of the experimental compounds/crude 
extract (test sample) in 50 µl of DMSO and diluted up to 1.0 ml with complete medium con-
taining antibiotics. 
The method of addition and serial dilution of the samples was applied. Thus, 20 µl of a 
solubilised compound was added in to the first well (duplicate or triplicate) and mixed well 
with the micropipette. 100 µl of sample was removed and added into the next well, mixed 
well, 100 µl removed and added into the next well until the 8th well was reached. The re-
maining 100 µl was discarded. In this manner, the first well received a final concentration of 
100 µg ml-1, and the last 0.78 µg ml
-l of the compound/crude extract to be tested. The plate 
was incubated in the dark at 25 °C for 3–5 days (preferably on an orbital shaker). 
After 5 days exposure, the drug activity was assessed microscopically using an improved 
Neubauer chamber (hemocytometer). Thus, using a micropipette, 10 µl of the culture was re-
moved and transferred to both chambers of the hemocytometer. Starting with chamber “o” of 
the hemocytometer, the cells were counted in the 1 mm centre square and the four 1 mm cor-
ner square at a magnification of 40×. The number of cells/ml was determined using the fol-
lowing formula: cells per ml = the average count per square×104, e.g., if the average counts 
per large square was 45 cells, then there were 4.5×105 cells/ml. 
The average number of parasites were counted in several negative control wells.19 The 
parasites exposed to varying concentration of the test compounds were counted and the % mor-
tality was calculated by the following formula: % survival = (no. of parasites test)×100/(no. of 
parasites negative control). 
RESULTS AND DISCUSSION 
The synthesized complexes were obtained pure in good yields and were air 
stable. They were characterized by elemental analysis, IR, multinuclear NMR spec-
troscopy and mass spectrometry and screened to check their biological activity. 
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Analytical and spectral characterization 
Ligand (HL1). Yield: 85 %; m.p. 127 °C. Anal. Calcd. for C10H7N3O7 
(M.W. 281): C, 42.70; H, 2.48; N, 14.94 %. Found: C, 42.74; H, 2.50; N, 14.51 %. 
IR (KBr, cm–1): 2850 (–OH), 3336 (–NH), 1769 (C=O), 1530 (COO)asym, 1314 
(COO)sym, 216 (Δν).  1H-NMR (CDCl3,  δ, ppm): 9.15 (d, [2.7] (N2O4– 
–C6H3), 4.35 (s, –NH), 8.24 (d, [2.6]), 8.27 (d, [2.6], –CH=CH), 9.10 (s, –OH). 
13C-NMR (CDCl3, δ, ppm): 142.9 (C1), 132.4 (C2), 118.8 (C3), 129.8 (C4), 123.8 
(C5), 128.6 (C6), 163.2 (C7), 152.6 (C8), 160.2 (C9), 172.0 (C10). EIMS (m/z, 
(relative abundance, %)): 183 (100) [C6H5N3O4]+, 99 (20) [C4H3O3]+, 72 (100) 
[C3H4O2]+, 55 (25) [C2HNO]+, 45 (62) [CHO2]+. 
Me2Sn(L1)2 (1). Yield: 75 %; m.p. 119 °C. Anal. Calcd. for C22H18N6O14Sn 
(M.W. 709): C, 37.23; H, 2.53; N, 11.84 %. Found: C, 37.27; H, 2.49; N, 11.80 %. 
IR (KBr, cm–1): 3334 (–NH), 1765 (C=O), 1578 (COO)asym, 1452 (COO)sym, 
126 (Δν), 526 (Sn−C), 408 (Sn−O). 1H-NMR (CDCl3, δ, ppm): 9.14 (d, [2.4], 
N2O4–C6H3), 4.35 (s, –NH), 8.21 (d, [2.8]), 8.24 (d, [2.8], –CH=CH), 0.91 (s 
(Sn–CH3). 13C-NMR (CDCl3, δ, ppm): 142.0 (C1), 131.1 (C2), 119.0 (C3), 129.4 
(C4), 123.9 (C5), 128.7 (C6), 162.2 (C7), 152.4 (C8), 161.5 (C9), 176.1 (C10), 6.4 
[535] (C11). EIMS (m/z, (relative abundance, %)): 709 (55) [R2Sn(OOCR′)2]+ or 
[M+], 696 (45) [RSn(OOCR′)2]+, 183 (82) [C6H5N3O4]+, 149 (45) [R2Sn]+, 134 
(55) [RSn]+, 123 (70) [C6H5NO2]+, 120 (15) [Sn]+, 91 (100) [C6H5N]+, 57 (80) 
[C2H2NO]+. 
Bu2Sn(L1)2 (2). Yield: 72 %; m.p. 142 °C. Anal. Calcd. for C28H32N6O14Sn 
(M.W. 795): C, 42.26; H, 4.02; N, 10.56 %. Found: C, 42.22; H, 4.06; N, 10.60 %. 
IR (KBr, cm–1): 3341 (–NH), 1762 (C=O), 1565 (COO)asym, 1435 (COO)sym, 
130 (Δν), 538 (Sn–C), 420 (Sn–O). 1H-NMR (CDCl3, δ, ppm): 9.08 (d, [2.5], 
N2O4–C6H3), 4.35 (s, –NH), 8.18 (d, [2.6]), 8.48 (d, [2.6], –CH=CH), 0.92 (t) 
1.26–1.36 (m), 1.39 (t, Sn–C4H9). 13C-NMR (CDCl3, δ, ppm): 142.6 (C1), 131.2 
(C2), 119.4 (C3), 129.5 (C4), 123.8 (C5), 128.2 (C6), 169.5 (C7), 152.1 (C8), 
161.6 (C9), 175.0 (C10), 13.5 (C11), 26.3 (C12), 26.9 (C13), 29.6 (C14). 119Sn-NMR 
(δ, ppm): –138.5. EIMS (m/z, (relative abundance, %)): 711 (55) [R2Sn(OOCR′)2]+, 
696 (45) [RSn(OOCR′)2]+, 149 (45) [R2Sn]+, 134 (55) [RSn]+, 120 (15) [Sn]+, 
86 (100) [C4H6O2]+, 57 (90) [C4H9]+. 
Oct2Sn(L1)2 (3). Yield: 68 %; m.p. 185 °C. Anal. Calcd. for C36H48N6O14Sn 
(M.W. 907): C, 47.62; H, 5.29; N, 9.26 %. Found: C, 47.66; H, 5.34; N, 9.30 %. 
IR (KBr, cm–1): 3342 (–NH), 1763 (C=O), 1591 (COO)asym, 1442 (COO)sym, 149 
(Δν), 536 (Sn–C), 422 (Sn–O). 1H-NMR (CDCl3, δ, ppm): 9.11 (d, [2.6], N2O4–
–C6H3), 4.35 (s, –NH), 8.19 (d, [2.6]), 8.52 (d, [2.6], –CH=CH), 0.89 (t), 1.75–1.80 
(m, Sn–C8H13). 13C-NMR (CDCl3, δ, ppm): 142.7 (C1), 131.1 (C2), 119.0 (C3), 
129.7 (C4), 123.5 (C5), 128.4 (C6), 165.6 (C7), 152.5 (C8), 161.7 (C9), 177.9 
(C10), 14.0 (C11), 24.8 (C12), 26.3 (C13), 27.0 (C14), 29.1 (C15), 29.6 (C16), 31.8 
(C17), 37.0 (C18). 119Sn-NMR (δ, ppm): –127.4. EIMS (m/z, (relative abundance, 
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%)): 907 (45) [R2Sn(OOCR′)2]+, 794 (35) [R2Sn(OOCR′)2]+, 345 (40) [R2Sn]+, 
232 (25) [RSn]+, 183 (78) [C6H5N3O4]+, 120 (12) [Sn]+, 86 (60) [C4H6O2]+
, 57 
(100) [C2H2NO]+, 43 (70) [C2H3O]+. 
Me3SnL1 (4). Yield: 78 %; m.p. 101 °C. Anal. Calcd. for C13H16N3O7Sn 
(M.W. 445): C, 35.05; H, 3.59; N, 9.43 %. Found: C, 35.01; H, 3.63; N, 9.39 %. 
IR (KBr, cm–1): 3332 (–NH), 1774 (C=O), 1589 (COO)asym, 1462 (COO)sym, 127 
(Δν), 532 (Sn–C), 418 (Sn–O). 1H-NMR (CDCl3, δ, ppm): 9.12 (d, [2.6], N2O4–
C6H3), 4.35 (s, –NH), 8.18 (d, [2.5], 8.94 (d, [2.5], –CH=CH), 0.65 (s, [57, 60], 
(Sn–CH3). 13C-NMR (CDCl3, δ, ppm): 148.6 (C1), 131.8 (C2), 119.1 (C3), 129.7 
(C4), 123.7 (C5), 128.9 (C6), 169.5 (C7), 152.6 (C8), 161.4 (C9), 178.2 (C10), –1.4 
[382,394] (C11). 119Sn-NMR (δ, ppm): 144.7. EIMS (m/z, (relative abundance, 
%)): 445 (50) [R3SnOOCR′]+, 430 (40) [R2SnOOCR′]+, 415 (60) [RSnOOCR′]+, 
183 (75) [C6H5N3O4]+, 164 (35) [R3Sn]+, 149 (38) [R2Sn]+, 120 (10) [Sn]+, 154 
(80) [C8H10O3]+, 57 (100) [C2H2NO]+, 43 (76) [C2H3O]+. 
Bu3SnL1 (5). Yield: 70 %; m.p. = 165 °C. Anal. Calcd. for C22H34N3O7Sn 
(M.W. 571): C, 46.23; H, 5.95; N, 7.35 %. Found: C, 46.27; H, 5.90; N, 7.39 %. 
IR (KBr, cm–1): 3330 (–NH), 1760 (C=O), 1545 (COO)asym, 1416 (COO)sym, 129 
(Δν), 540 (Sn–C), 426 (Sn–O). 1H-NMR (CDCl3, δ, ppm): 9.11 (d, [2.5], N2O4–
C6H3), 4.35 (s, –NH), 8.19 (d, [2.6]), 8.46 (d, [2.6], –CH=CH), 0.93 (t), 1.27–1.36 
(m), 1.63 (t, Sn-C4H9). 13C-NMR (CDCl3, δ, ppm): 142.2 (C1), 132.3 (C2), 119.2 
(C3), 129.7 (C4), 123.9 (C5), 128.3 (C6), 169.3 (C7), 152.3 (C8), 161.2 (C9), 
175.6 (C10), 17.4 [325, 341] (C11), 26.8 [22.4] (C12), 27.8 [62.6, 65.2] (C13), 
29.6 (C14). 119Sn-NMR (δ, ppm): 152.2. EIMS (m/z, (relative abundance, %)): 
571 (20) [R3SnOOCR′]+, 514 (40) [R2SnOOCR′]+, 290 (35) [R3Sn]+, 233 (45) 
[R2Sn]+, 183 (75) [C6H5N3O4]+, 120 (25) [Sn]+, 86 (55) [C4H6O2]+, 57 (100) 
[C2H2NO]+, 43 (76) [C2H3O]+. 
Ph3SnL1 (6). Yield: 72 %; m.p. 95 °C. Anal. Calcd. for C28H22N3O7Sn (M.W. 
779): C, 43.13; H, 2.82; N, 5.39. Found: C, 43.17; H, 2.78; N, 5.34. IR (KBr,  
cm–1): 3339 (–NH), 1772 (C=O), 1555 (COO)asym, 1420 (COO)sym, 135 (Δν), 411 
(Sn–O). 1H-NMR (CDCl3, δ, ppm): 9.12 (d, [2.6], N2O4–C6H3), 4.35 (s, −NH), 
8.15 (d, [2.5]), 8.38 (d, [2.6], –CH=CH), 7.48–7.75 (m, Sn–C6H5);  13C-NMR 
(CDCl3, δ, ppm): 142.2 (C1), 130.3 (C2), 119.1 (C3), 129.5 (C4), 124.0 (C5), 
128.5 (C6), 169.5 (C7), 152.4 (C8), 161.3 (C9), 176.4 (C10), 137.4 (C11), 136.1 
(C12), 129.0 (C13), 128.7 (C14).  119Sn-NMR (δ, ppm): –52.4. EIMS  (m/z, 
(relative abundance, %)): 631 (30) [R3SnOOCR′]+, 554 (20) [R2SnOOCR′]+, 
350 (45) [R3Sn]+, 273 (50) [R2Sn]+, 196 (45) [RSn]+, 120 (15) [Sn]+, 154 (80) 
[C8H10O3]+, 57 (100) [C2H3NO]+. 
Ligand (HL2). Yield: 84 %; m.p. 138 °C. Anal. Calcd. for C14H9N3O7 
(M.W. 331): C, 50.75; H, 2.71; N, 12.68 %. Found: C, 51.71; H, 2.67; N, 12.64 
%. IR (KBr, cm–1): 3189 (–OH), 3325 (–NH), 1790 (C=O), 1584 (COO)asym, 
1328 (COO)sym, 256 (Δν). 1H-NMR (CDCl3, δ, ppm): 7.94 (m, N2O4–C6H3), 
4.12 (s, –NH), 8.04 (m, –CO–C6H4–CO), 8.26 (s, –OH). 13C-NMR (CDCl3, δ, 
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ppm): 162.7 (C1), 118.9 (C2), 129.9 (C3), 123.9 (C4), 128.5 (C5), 131.3 (C6), 
142.0 (C7), 129.1 (C8), 152.5 (C9), 136.0 (C10,10`), 129.7 (C11,11`), 170.5 (C12). 
EIMS  (m/z, (relative abundance, %)): 183 (100) [C6H3N3O4]+, 153 (24) 
[C6H5NO4]+, 107 (16) [C7H7O]+, 91 (25) [C6H5N]+. 
 
Scheme 2. NMR numbering scheme for organotin(IV) derivatives of 
2-{[(2,4-dinitrophenyl)amino)]carbonyl}benzoic acid (HL2). 
Me2Sn(L2)2 (7). Yield: 65 %; m.p. 148 °C. Anal. Calcd. for C30H24N6O14Sn 
(M.W. 811): C, 44.38; H, 2.95; N, 10.35 %. Found: C, 44.42; H, 2.91; N, 10.31 %. 
IR (KBr, cm–1): 3318 (–NH), 1791 (C=O), 1581 (COO)asym, 1422 (COO)sym, 
159 (Δν), 522 (Sn–C), 416 (Sn–O). 1H-NMR (CDCl3, δ, ppm): 7.74 (m, N2O4– 
C6H3), 4.11 (s, –NH), 8.33 (m, –CO–C6H4–CO), 1.26 (s, Sn–CH3). 13C-NMR 
(CDCl3, δ, ppm): 142.5 (C1), 119.7 (C2), 129.2 (C3), 123.7 (C4), 128.4 (C5), 
131.5 (C6), 165.0 (C7), 128.4 (C8), 152.6 (C9), 137.3 (C10,10’), 127.2 (C11,11’), 
172.7 (C12), 8.4 [532] (C13). 119Sn-NMR (δ, ppm): –185.6. EIMS (m/z, (relative 
abundance, %)): 167 (52) [C6H3N2O9]+, 149 (6) [SnR2]+, 121 (8) [SnH]+, 91 
(84) [C6H5N]+, 86 (90) [C4H6O2]+, 84 (100) [C4H4O2]+, 77 (8) [C6H5]+. 
Bu2Sn(L2)2 (8). Yield: 79 %; m.p. 179 °C. Anal. Calcd. for C36H36N6O14Sn 
(M.W. 895): C, 48.26; H, 4.02; N, 9.38 %. Found: C, 48.22; H, 4.06; N, 9.42. IR 
(KBr, cm–1): 3323 (–NH), 1783 (C=O), 1578 (COO)asym, 1430 (COO)sym, 148 (Δν), 
528 (Sn–C), 412 (Sn–O). 1H-NMR (CDCl3, δ, ppm): 7.91 (m, N2O4–C6H3), 4.10 
(s, –NH), 8.03 (m, –CO–C6H4–CO), 1.35 – 1.38 (m), 1.93 (t, Sn–C4H9); 13C-NMR 
(CDCl3, δ, ppm): 142.6 (C1), 121.3 (C2), 129.5 (C3), 123.9 (C4), 128.2 (C5), 
131.1 (C6), 167.2 (C7), 128.2 (C8), 152.4 (C9), 136.2 (C10,10`), 124.5 (C11,11`), 
176.2 (C12), 14.0 (C13), 22.6 (C14), 29.3 (C15), 31.8 (C16). 119Sn-NMR (δ, ppm): 
–137.5. EIMS (m/z, (relative abundance, %)): 267 (100) [C6H3N2O9]+, 233 (8) 
[SnR2]+, 176 (9) [SnR]+, 77 (67) [C6H5]+, 57 (84) [C4H9]+. 
Oct2Sn(L2)2 (9). Yield: 66 %; m.p.135 °C. Anal. Calcd. for C44H52N6O14Sn 
(M.W. 1007): C, 52.43; H, 5.16; N, 8.34 %. Found: C, 52.47; H, 5.12; N, 8.38 %. 
IR (KBr, cm–1): 3320 (–NH), 1793 (C=O), 1569 (COO)asym, 1428 (COO)sym, 141 
(Δν), 530 (Sn–C), 418 (Sn–O). 1H-NMR (CDCl3, δ, ppm): 7.93 (m, N2O4–C6H3), 
4.12 (s, –NH), 8.02 (m, –CO–C6H4–CO), 0.90, 1.17 – 1.28 (m), 1.72–1.78 (m, 
Sn–C8H13).  13C-NMR (CDCl3,  δ, ppm): 142.2 (C1), 118.9 (C2), 129.1 (C3), 
123.7 (C4), 128.4 (C5), 131.4 (C6), 167.4 (C7), 128.4 (C8), 152.9 (C9), 136.5 
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(C10,10`), 124.6 (C11,11`), 177.4 (C12), 14.1 (C13), 22.6 (C14), 25.8 (C15), 26.2 
(C16), 29.3 (C17), 29.3 (C18), 31.8 (C19), 33.4 [101] (C20). 119Sn-NMR (δ, ppm): 
–139.2. EIMS (m/z, (relative abundance, %)): 345 (4) [SnR2]+, 232 (3) [SnR]+, 
167 (67) [C6H3N2O4]+, 91 (18) [C6H5N]+, 85 (56) [C4H5O2]+, 57 (100) [C4H9]+. 
Me3SnL2 (10). Yield; 72 %; m.p. 101 °C. Anal. Calcd. for C17H18N3O7Sn 
(M.W. 495): C, 41.21; H, 3.63; N, 8.48 %. Found: C, 41.25; H, 3.67; N, 8.52 %. 
IR (KBr, cm–1): 3326 (–NH), 1780 (C=O), 1593 (COO)asym, 1415 (COO)sym, 178 
(Δν), 542 (Sn–C), 422 (Sn–O). 1H-NMR (CDCl3, δ, ppm): 7.92 (m, N2O4–C6H3), 
4.11 (s, –NH), 8.66 (m, –CO–C6H4–CO), 0.88 (s, [57], Sn–CH3).  13C-NMR 
(CDCl3, δ, ppm): 142.6 (C1), 119.6 (C2), 129.4 (C3), 123.6 (C4), 128.0 (C5), 
131.5 (C6), 165.2 (C7), 128.0 (C8), 152.4 (C9), 136.2 (C10,10`), 125.2 (C11,11`), 
171.4 (C12), –1.6 [383,395] (C13). 119Sn-NMR (δ, ppm): 111.6. EIMS (m/z, (re-
lative abundance, %)):166 (22) [C6H2N2O4]+, 164 (16) [SnR3]+, 149 (28) [SnR2]+, 
134 (6) [SnR]+, 120 (7) [Sn]+, 91 (11) [C6H5N]+, 77 (37) [C6H5]+, 57 (100) 
[C4H9]+. 
Ph3SnL2 (11). Yield: 55 %; m.p. 163 °C; Anal. Calcd. for C32H24N3O7Sn 
(M.W. 681): C, 56.38; H, 3.52; N, 6.16 %. Found: C, 56.34; H, 3.48; N, 6.20 %. 
IR (KBr, cm–1): 3324 (–NH), 1788 (C=O), 1572 (COO)asym, 1410 (COO)sym, 162 
(Δν), 425 (Sn–O). 1H-NMR (CDCl3, δ, ppm): 7.95 (m, N2O4–C6H3), 4.13 (s,  
–NH), 8.65 (m, –CO–C6H4–CO), 7.28–7.59 (m, Sn–C6H5). 13C-NMR (CDCl3, δ 
[117/119Sn–13C], ppm): 142.1 (C1), 118.2 (C2), 129.5 (C3), 123.7 (C4), 128.4 
(C5), 131.2 (C6), 168.8 (C7), 128.4 (C8), 152.7 (C9), 136.4 (C10,10`), 125.5 
(C11,11`), 182.1 (C12), 136.2 [46, 48] (C13), 135.8 (C14), 128.0 [62, 65] (C15), 
127.5 [13] (C16). 119Sn-NMR (δ, ppm): –109.75.; EIMS (m/z, (relative abundan-
ce, %)): 350 (4) [SnR3]+, 315 (10) [C14H8N3O6]+, 309 (95) [C20H25O3]+, 273 
(5) [SnR2]+, 196 (7) [SnPh]+, 154 (100) [C8H10O3]+, 120 (10) [Sn]+, 77 (20) 
[C6H5]+. 
Infrared spectra 
The FTIR data are consistent with the formation of compounds with the 
composition R2SnL2 and R3SnL. The carboxylate groups of the ligand coordi-
nate to the metal ion in different modes as shown in Scheme 3.20 The disap-
pearance of a broad band in the spectra of the complexes in the region 3200– 
–2800 cm–1, which was present in the free ligands, suggests deprotonation of the 
free COOH group upon complexation. The bonding of the tin(IV) to the ligand 
was confirmed by the presence of Sn–O bands in the range of 426–408 cm–1.21 
Sn–C absorption bands in the region of 542–520 cm–1 were observed in all com-
plexes. 
Based on the difference between ν(COO)sym and ν(COO)asym and the cor-
responding band position, it is proposed that the carboxylate group acts as bi-
dentate in all these complexes in the solid state.22 According to Lebl et al.,23 the 
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values Δν (Δν = ν (COO)asym – ν(COO)sym) can be divided into three groups: 
(a) when Δν(COO) > 350, the compounds contain, with a high probability, a mo-
nodentate carboxylate group. However, other very weak intra- and intermolecular 
interactions cannot be excluded; (b) when Δν(COO) < 200, the carboxylate groups 
of these compounds can be considered to be practically bidentate; (c) compounds 
where Δν(COO) is between 350 and 200 are considered as intermediate between 
monodentate and bidentate, which is called anisobidentate. It has also been sug-
gested that the Δν(COO) value in the chelating mode is less than Δν(COO) in the 
bridging mode.20 Some characteristic vibrational frequencies of different groups 
fall within the range ν(C=O) 1793–1762 cm
−1 and ν(N–H) 3342–3320 cm–1. 
 
Scheme 3. Possible coordination modes of the carboxylate group to the metal. 
1H-NMR spectra 
The 1H-NMR spectra for the investigated compounds were recorded in deu-
terated chloroform at room temperature. Different protons were assigned based 
on their multiplicity and intensity patterns. The integration of the spectra was in 
accordance with the number of protons proposed for each molecular fragment. 
The 1H-NMR spectra of the complexes exhibited useful features. 
In the studied complexes, the COOH resonance of the ligands was absent, 
which suggests the replacement of the carboxylic proton by the organotin(IV) 
moiety. Charge donation from the COO– donor to the tin atom decreased the 
electron density and resulted in a deshielding of the ligand protons. Singlets and 
multiplets were observed in the case of the methyl and phenyl groups, respec-
tively. Simultaneously, the signals of the aromatic protons were shifted down-
field because of the ring current effect. The aromatic protons of the phenyl group 
and the benzoate group were assigned with difficulty due to the narrow range on 
the NMR scale, hence the phenyl group gave a multiplet due to a complex 
pattern. The alkyl groups bonded to tin were assigned in their characteristic ran-
ge. The nJ(119Sn,1H) for the dimethyl and trimethyltin(IV) derivatives had appro-
ximately the same value, confirming a tetrahedral environment in solution, i.e., 
the carboxylate groups act as monodentate in solution. The nJ(1H,1H) values for 
the different compounds suggest that the protons of the ethylene group (HC=HC) 
were in the cis-position.24 In all diorganotin(IV) and triorganotin(IV) derivatives, 
the –NH resonance was observed as a broad or a sharp weak signal. The aromatic 
proton resonances were assigned by comparing the experimental chemical shifts 
with those calculated by the incremental method.25 In triorganotin carboxylates, 
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the 
2J[119Sn,1H] values for the triorganotin compounds suggest tetrahedral geo-
metry (Fig. 1(a)) of the tin atom. 
Unlike the triorganotin carboxylates in solution, the geometry of diorganotin 
dicarboxylates cannot be defined with certainty because of dynamic processes 
involving different modes of coordination of the carboxylate oxygens to the tin 
atom.26 However, in the solid state, the tin atom is mostly hexa-coordinated in 
such systems (Fig.1(b)).27 
 
Fig. 1. Suggested structures of the complexes. 
13C-NMR spectra 
The 13C-NMR spectra of the organotin(IV) derivatives are consistent with 
the following observations: 
According to 13C-NMR data, the involvement of the carboxylate group in 
the bonding to Sn was confirmed by the resonance of the carboxylic carbon in all 
the compounds, which exhibited a lower shift after coordination as compared 
with the ligands, suggesting the coordination of the ligand through a carboxylic 
oxygen to the organotin(IV) moiety. The remaining carbons did not shift signi-
ficantly after complexation. 
The carbon of the phenyl and alkyl groups attached to tin were observed at 
almost similar positions as calculated by the incremental method24 and reported 
in the literature.28–32 Two resonances were observed in the expected range for 
the carboxyl and amide groups. 
The tributyltin and trimethyltin complexes of the present investigation ex-
hibit  1J(13C,117/119Sn) coupling satellites in the range 325–363 Hz in CDCl3 
solution, suggesting that the tin atom is four-coordinated in solution.33–36 
119Sn-NMR spectra 
The  119Sn chemical shifts of the organotin compounds covered a range 
δ±600. As the electron releasing power of the alkyl group bonded to tin in-
creases, the tin atom becomes progressively more shielded and the δ(119Sn) value 
moves to a higher field.37 It was reported earlier that 119Sn-NMR is also a po-
werful technique and the value of δ(119Sn) is directly linked to the coordination 
number of the central tin atom.38 
In all the complexes, the 119Sn spectra show only a sharp singlet, indicating 
the formation of single species. In general, the 119Sn chemical shifts move to 
lower frequency with increasing coordination number, although the shift ranges 
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are somewhat dependent on the nature of the substituents at the tin atom. In all 
the complexes, the 119Sn chemical shift values for the triorganotin complexes 
agree well with a tetrahedral environment around the tin atom in non-coordinated 
solvents, whereas those of the diorganotin complexes indicate penta coordina-tion, 
i.e., the tendency towards increased coordination number decreases as the num-
ber of R groups increases. However, in solution, such structures appear four-co-
ordinate, the additional coordination from the carbonyl oxygen to tin being lost.39 
Mass spectrometry 
Mass spectra for the investigated compounds were recorded at 70 eV for all 
di- and tri-organotin(IV) derivatives. Molecular ion peaks of very low intensity 
are observed in few complexes.40 In the di- and tri-organotin(IV) derivatives, a 
rather similar pattern of fragmentation was observed. In both cases, primary frag-
mentation was due to the successive loss of R groups followed by the elimination 
of CO2 from the ligand and then the remaining part of the ligand, which leaves 
Sn+ or SnH+ as the end product. The second route of fragmentation was the loss 
of CO2 and other neutral species, which ultimately gives [C6H5]+ in the first step. 
Another possible route is the disintegration of the ligand and stepwise elimina-
tion of R groups to Sn+ or SnH+ as the residue. 
Biological activity 
The results of the antibacterial activities are given in Table I. The screening 
tests show that the phenyltin carboxylates were the most potent candidates 
against the tested bacteria. The activity of the other derivatives varies according 
to their R groups. 
TABLE I. Antibacterial activity data for R2Sn(L1)2/R2Sn(L2)2 and R3SnL1/R3SnL2 
Bacterium 
Zone of inhibition, mm 
Compound number 
1 2 3 4 5 6 7 8 9  10  11 
Escherichia coli  10  −  10 14 14 20  −  − 16 − 10 
Bacillus subtilis  10  − 12 − 14  10 −  − 27 − 10 
Shigella flexenari  10  − 14  14 −  −  −  − 18 −  − 
Staphylococcus aureus  −  − 14  20 −  −  −  − 14 −  − 
Pseudomonas aeruginosa  −  −  −  − 14  16 −  − 18 − 16 
Salmonella typhi  10  − 14  10 −  −  −  − 20 − 18 
The LD50 data are summarized in Table II. A previous report41 showed that 
the nature of the organic group is responsible for the toxicity of organotin com-
pounds. Compound 5 did not show any toxicity at all. 
The insecticidal activity data of the compounds are given in Table III. The 
trimethyltin(IV) carboxylate of HL2 was inactive against the tested insects, while 
the other organotin(IV) carboxylates exhibited activity. This can be explained as 
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follows: as the length or number of the R group increases, the activity also in-
creases. 
TABLE II. Cytotoxicity data for R2Sn(L1)2/R2Sn(L2)2 and R3SnL1/R3SnL2 (standard drug: 
etoposide, LD50 = 7.4625 μg/ml) 
Compound  1 2 3 4 5 6 7 8 9  10  11 
LD50 / μg ml-1  8.64 9.14 8.00 7.99  − 5.18  16.89 16.89 13.92 14.29  18.19 
TABLE III. Insecticidal data for R2Sn(L1)2/R2Sn(L2)2 and R3SnL1/R3SnL2. Concentration of 
samples: 1571.2 μg/ml. Standard drug: Permethrin (235.7 μg/ml) 
Compound  1 2 3 4 5 6 7 8 9  10  11 
IC50 /μg/ml  62.12  − 65.71 64.50 64.80 − 60  65  67.8  65.5  65 
Leishmaniases is a class of diseases caused by protozoan haemoflagellates of 
the genus Leishmania. The disease is transmitted by female sandflies (Phlebo-
tomus or Lutzomya) that feed on the blood of an animal or human host. The 
disease occurs in most tropical and sub-tropical areas of the world. The anti-
leishmanial activity data of the complexes are given in Table IV. All the com-
pounds showed antileishmanial activity with a few exceptions. 
TABLE IV. Antileishmanial activity data for R2Sn(L1)2/R2Sn(L2)2 and R3SnL1/R3SnL2. Test 
Organism-Leishmanial major (DESTO). Standard drug: Amphotericin B (0.19 μg/ml) 
Insect 
Compound 
1 2 3 4 5 6 7 8 9  10  11 
Tribolium castaneum  25 25 25 25 25 25 40 20 25  − 20 
Sitophilus oryzae  25 25 25 25 25 25  −  − 25 − 20 
Rhyzoperthadominia  50 50 20 25  − 25  25 − 25 −  − 
Callosbruchus analis  25 25 25 25 25 22 25  − 60 − 40 
CONCLUSIONS 
The synthesis of R2SnL2 and R3SnL resulted in compounds with a 1:1 or 1:2 
metal-to-ligand ratio in good yield. The FTIR data evidenced the formation of 
well-defined complexes by the appearance of the Sn–O band. The NMR data 
were analyzed and almost all their signals were assigned. The di- and tri-orga-
notin complexes were proposed to have penta- and tetra-coordinated geometry 
around tin atom in solution, confirmed by the 13C,117/119Sn satellites, as well as 
1H- and 119Sn-NMR data. The results demonstrated that the effect of different 
alkyl groups was minor. The screening results show that the reported complexes 
1–11 exhibited good biological activity with a few exceptions. 
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ИЗВОД 
СИНТЕЗА, КООРДИНАЦИЈА И БИОЛОШКИ АСПЕКТИ ОРГАНОКАЛАЈ(IV) ДЕРИВАТА 
4-[(2,4-ДИНИТРОФЕНИЛ)АМИНО]-4-ОКСО-2-БУТЕНСКЕ АКРИЛНЕ КИСЕЛИНЕ И 
2-{[(2,4-ДИНИТРОФЕНИЛ)АМИНО]КАРБОНИЛ} БЕНЗОЕВЕ КИСЕЛИНЕ 
KHADIJA SHAHID1, SAIRA SHAHZADI2 и SAQIB ALI1 
1Department of Chemistry, Quaid-i-Azam University, Islamabad – 45320 и 2Department of Chemistry, 
GC University, Faisalabad, Pakistan 
Синтетисана је нова серија органокалај(IV) комплекса анилинских деривата, R2SnL2 и 
R3SnL [где  је R = Me, n-Bu, Ph, n-Oct],  реакцијом HL1  и HL2  са  одговарајућим  органо-
калајним халогенидима или оксидима. Дати су експериментални детаљи за добијање и ка-
рактеризацију (укључујући елементалну анализу, IR и мултинуклеарну NMR (1H, 13C и 119Sn 
спектри у CDCl3) и EI масенe спектрe) обе серије. Везујућа места лиганада су идентифико-
вана помоћу FTIR спектроскопских мерења, и нађено је да у свим случајевима органокалај-
ни(IV) део реагује са кисеоником COO– групе градећи нове комплексе. У диорганокалајним ком-
плексима у чврстом стању COO– група је координована за органокалај(IV) центре као биден-
тат. 119Sn-NMR подаци и nJ(13C–119/117Sn) константа купловања у складу су са тетраедар-
ском координационом геометријом органокалајних комплекса у растварачима који немају 
координациона својства. Tакође је објављена биолошка активност ових једињења (антибак-
теријска, антифунгална, инсектицидна, цитотоксичност и против протозоа из рода Leishmania). 
(Примљено 29. фебруара, ревидирано 13. јуна 2008) 
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